Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISA 2022 | Session highlights: closing the gap of basic and clinical research in AL and ATTR amyloidosis

Vittorio Bellotti • 5 Sep 2022
ISA 2022
Amyloidosis Rare Diseases

Vittorio Bellotti, MD, PhD, University of Pavia, Pavia, Italy, briefly highlights some of the topics that were presented in a session at ISA 2022, which focused on closing the gap of basic and clinical research in amyloidosis. Dr Bellotti also discusses the value of generating and improving models used to understand the biology of this disease. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

More from Vittorio Bellotti

1:15
Bridging the gap between in vitro and in vivo models of amyloid formation
Vittorio Bellotti • 5 Sep 2022

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:11
Personalized risk assessment for transplantation in primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
1:18
Autologous gene editing using the CRISPR system to treat primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
0:58
Hematological manifestations associated with primary immunodeficiency disorders
Thomas Fox • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals